• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A study on the fate of curcumin in the rat.

作者信息

Wahlström B, Blennow G

出版信息

Acta Pharmacol Toxicol (Copenh). 1978 Aug;43(2):86-92. doi: 10.1111/j.1600-0773.1978.tb02240.x.

DOI:10.1111/j.1600-0773.1978.tb02240.x
PMID:696348
Abstract

The uptake, distribution and excretion of curcumin in Sprague-Dawley rats has been studied. When administered orally in a dose of 1 g/kg, curcumin was excreted in the faeces to about 75%, while negligible amounts of curcumin appeared in the urine. Measurements of blood plasma levels and biliary excretion showed that curcumin was poorly absorbed from the gut. No apparent toxic effects were seen after doses of up to 5 g/kg. When intravenously injected or when added to the perfusate of the isolated liver, curcumin was actively transported into bile, against concentration gradients of several hundred times. The major part of the drug was however metabolized. In suspensions of isolated hepatocytes or liver microsomes 90% of the added curcumin was metabolized within 30 min. In view of the poor absorption, rapid metabolism and excretion of curcumin, it is unlikely that substantial concentrations of curcumin occur in the body after ingestion.

摘要

相似文献

1
A study on the fate of curcumin in the rat.
Acta Pharmacol Toxicol (Copenh). 1978 Aug;43(2):86-92. doi: 10.1111/j.1600-0773.1978.tb02240.x.
2
Absorption and tissue distribution of curcumin in rats.
Toxicology. 1980;16(3):259-65. doi: 10.1016/0300-483x(80)90122-5.
3
Metabolism of curcumin--studies with [3H]curcumin.姜黄素的代谢——用[3H]姜黄素进行的研究
Toxicology. 1981;22(4):337-44. doi: 10.1016/0300-483x(81)90027-5.
4
The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat.姜黄素(1,7-双-(4-羟基-3-甲氧基苯基)-1,6-庚二烯-3,5-二酮)在大鼠体内的代谢与排泄
Xenobiotica. 1978 Dec;8(12):761-8. doi: 10.3109/00498257809069589.
5
Absorption, distribution, metabolism and excretion of telmesteine, a mucolitic agent, in rat.黏液溶解剂泰尔司特因在大鼠体内的吸收、分布、代谢及排泄情况
Xenobiotica. 2003 Jul;33(7):755-65. doi: 10.1080/0049825031000108324.
6
Arsenic speciation in bile and urine following oral and intravenous exposure to inorganic and organic arsenics in rats.大鼠经口和静脉暴露于无机砷和有机砷后胆汁和尿液中的砷形态
Toxicol Sci. 2004 Dec;82(2):478-87. doi: 10.1093/toxsci/kfh265. Epub 2004 Sep 1.
7
Excretion and metabolism of remikiren, a potent orally active inhibitor of primate renin.瑞米吉仑(一种强效口服活性灵长类肾素抑制剂)的排泄与代谢。
Xenobiotica. 1996 Mar;26(3):285-95. doi: 10.3109/00498259609046708.
8
Metabolic fate of poly-(lactic-co-glycolic acid)-based curcumin nanoparticles following oral administration.口服给药后聚(乳酸-乙醇酸)基姜黄素纳米颗粒的代谢命运。
Int J Nanomedicine. 2016 Jun 28;11:3009-22. doi: 10.2147/IJN.S107442. eCollection 2016.
9
Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.给斯普拉格-道利大鼠静脉注射、口服和气管内给予3H-醋酸艾洛米松后的药代动力学、蛋白结合及代谢情况
Arzneimittelforschung. 1998 Apr;48(4):371-8.
10
The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.抗蠕虫药甲基-14C-5-环丙基羰基-2-苯并咪唑氨基甲酸酯(环苯达唑)对大鼠和犬给药后的放射性分布情况。
Arzneimittelforschung. 1977;27(3):593-8.

引用本文的文献

1
Curcumin as a promising therapeutic agent for diabetic neuropathy: from molecular mechanisms to functional recovery.姜黄素作为治疗糖尿病神经病变的一种有前景的治疗药物:从分子机制到功能恢复
Diabetol Metab Syndr. 2025 Aug 5;17(1):314. doi: 10.1186/s13098-025-01884-5.
2
Pharmacokinetic Analysis of the Bioavailability of AQUATURM, a Water-Soluble Curcumin Formulation, in Comparison to a Conventional Curcumin Tablet, in Human Subjects.水溶性姜黄素制剂AQUATURM与传统姜黄素片剂在人体受试者中的生物利用度的药代动力学分析。
Pharmaceuticals (Basel). 2025 Jul 21;18(7):1073. doi: 10.3390/ph18071073.
3
Therapeutic Potential of Curcumin and Novel Formulations in Psoriasis Treatment: Evidence and Future Prospects.
姜黄素及其新型制剂在银屑病治疗中的治疗潜力:证据与未来展望
Drug Des Devel Ther. 2025 Jun 25;19:5387-5414. doi: 10.2147/DDDT.S520555. eCollection 2025.
4
Targeting mTOR with curcumin: therapeutic implications for complex diseases.用姜黄素靶向雷帕霉素靶蛋白:对复杂疾病的治疗意义。
Inflammopharmacology. 2025 Apr;33(4):1583-1616. doi: 10.1007/s10787-025-01643-y. Epub 2025 Feb 16.
5
Exploring the role of curcumin in mitigating oxidative stress to alleviate lipid metabolism disorders.探索姜黄素在减轻氧化应激以缓解脂质代谢紊乱中的作用。
Front Pharmacol. 2025 Jan 30;16:1517174. doi: 10.3389/fphar.2025.1517174. eCollection 2025.
6
Curcumin in Ophthalmology: Mechanisms, Challenges, and Emerging Opportunities.眼科中的姜黄素:作用机制、挑战与新机遇
Molecules. 2025 Jan 21;30(3):457. doi: 10.3390/molecules30030457.
7
Harnessing Nature's Toolbox: Naturally Derived Bioactive Compounds in Nanotechnology Enhanced Formulations.利用自然的工具箱:纳米技术增强配方中的天然衍生生物活性化合物
ACS Omega. 2024 Oct 18;9(43):43302-43318. doi: 10.1021/acsomega.4c07756. eCollection 2024 Oct 29.
8
EF24, a Curcumin Analog, Reverses Interleukin-18-Induced miR-30a or miR-342-Dependent TRAF3IP2 Expression, RECK Suppression, and the Proinflammatory Phenotype of Human Aortic Smooth Muscle Cells.EF24,姜黄素类似物,逆转白细胞介素-18 诱导的 miR-30a 或 miR-342 依赖性 TRAF3IP2 表达、RECK 抑制和人主动脉平滑肌细胞的促炎表型。
Cells. 2024 Oct 10;13(20):1673. doi: 10.3390/cells13201673.
9
Targeting STAT3 signaling pathway by curcumin and its analogues for breast cancer: A narrative review.姜黄素及其类似物靶向STAT3信号通路治疗乳腺癌:一项叙述性综述。
Animal Model Exp Med. 2024 Dec;7(6):853-867. doi: 10.1002/ame2.12491. Epub 2024 Sep 2.
10
Preparation, Characterization, and Antioxidant Properties of Self-Assembled Nanomicelles of Curcumin-Loaded Amphiphilic Modified Chitosan.载姜黄素两亲改性壳聚糖自组装纳米胶束的制备、表征及抗氧化性能
Molecules. 2024 Jun 6;29(11):2693. doi: 10.3390/molecules29112693.